Introduction:

the fear to diabetic foot is a sequela of two chronic complications of diabetes mellitus, peripheral neuropathy and vascular insufficiency.

Objective:

to assess the impact of the intra-lesion application of Heberprot-P to patients with diabetic-foot ulcers in Pinar de Rio province from January 2012 to May 2014.

Methods:

an intervention, descriptive, retrospective and cross-sectional study was carried out in patients with diabetic-foot ulcers treated with Heberprot-P in the period 2012-2014. The target group comprised 2 225 diabetic patients and a sample of 2 060 with diabetic foot, using the descriptive statistics by means of absolute frequencies and relative percentages.

Results:

type-2 diabetes mellitus prevailed (88 %), having 20 health facilities for the treatment, mainly outpatient clinics, 75 % of the consultations were possible due to increased employment in Primary Health Care and generally for years, neuroinfectious diabetic foot (88 %) and Wagner’s 2 (64 %) predominated; it was necessary to perform major amputation for 0,9 % of the cases.

Conclusions:

the extension on the application of Heberprot-P to diabetic foot is beneficial thanks to the multiple health facilities involved in this task along with the training of doctors of medicine, nursing care personnel and podiatrists, making possible the increase of ambulatory care in Primary Health Care and the early diagnosis of the lesions, decreasing at the same time, the costs of the hospital stays, reaching the service to those who needed it, with 99,0 % of effectiveness and a low percentage of amputation, improving the quality of life.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )